In particular, Li et al. (2013) demonstrated that SFN is able to mitigate the BBB damage by inhibiting MMP-9 expression in an in vivo model of experimental autoimmune encephalomyelitis. The gene discussed is MMP9; the disease is experimental autoimmune encephalomyelitis.